Frances Hackman

Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection

David A. Cooper, Jayvant Heera, James Goodrich et al. · The Journal of Infectious Diseases · 2010 · 265 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effort

Rachel J. Church, Gerd A. Kullak‐Ublick, Jiri Aubrecht et al. · Hepatology · 2018 · 243 citations · Full text

Veterinary Medicine, Pharmacology, Toxicology +17

Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir

Ravi Shankar Prasad Singh, Sima S. Toussi, Frances Hackman et al. · Clinical Pharmacology & Therapeutics · 2022 · 156 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms

Jeffrey R. Stokes, F.A. Romero, Richard Allan et al. · Journal of Allergy and Clinical Immunology · 2011 · 58 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients

Gerd Fätkenheuer, Schlomo Staszewski, Andreas Plettenburg et al. · AIDS · 2009 · 43 citations

Pharmacy, Pharmacology, Pharmacotherapy +17